clinical studies on the beneficial effects
of coenzyme Q10 for cancer patientshave
not only documented clinical improvements,
but also have identified probable mechanisms
by which CoQ10 may help slow tumor growth.
Some of these mechanisms include immune
augmentation, suppression of vascular endothelial
growth factor (that facilitates tumor angiogenesis),
and reduction of inflammatory markers that
may facilitate cancer cell propagation.
and breast cancer are two types
of malignancies for which CoQ10 has demonstrated
substantial clinical benefit.1,2 Regrettably,
the media and cancer establishment have
ignored these promising discoveries that
could save many lives.
a recent melanoma study compared the effects
of administering alpha interferon
with or without daily CoQ10 (400
mg). There was an astounding 10-fold lower
risk of metastasis in the CoQ10-supplemented
group! This effect was even more pronounced
for those with more advanced melanoma, where
CoQ10-supplemented patients were 13 times
less likely to develop metastasis. Alpha
interferon is an immune boosting drug that
can induce side effects so severe that patients
have to discontinue it. In this study,2
only 22% of CoQ10-supplemented patients
developed side effects compared to 82% not
taking supplemental CoQ10.
article at: http://www.lef.org